CD40L coding oncolytic adenovirus 3 is a potent facilitator of dendritic cell therapy.

Sadia Zafar, Mikko Oskari Siurala, Suvi Sorsa, Otto Jooseppi Hemminki, Riikka Sari Annika Havunen, Siri Tähtinen, Simona Bramante, Lotta Vassilev, Hongjie Wang, Andre Lieber, Silvio Hemmi, Tanja de Gruijl, Anna-Maija Kanerva, Akseli Eetu Hemminki

Forskningsoutput: KonferensbidragPoster

Originalspråkengelska
StatusPublicerad - 2017
EvenemangESMO immuno-oncology conference 2017 - Geneva, Schweiz
Varaktighet: 7 dec 201710 dec 2017

Konferens

KonferensESMO immuno-oncology conference 2017
LandSchweiz
OrtGeneva
Period07/12/201710/12/2017

Vetenskapsgrenar

  • 3122 Cancersjukdomar
  • 3111 Biomedicinska vetenskaper

Citera det här

Zafar, S., Siurala, M. O., Sorsa, S., Hemminki, O. J., Havunen, R. S. A., Tähtinen, S., ... Hemminki, A. E. (2017). CD40L coding oncolytic adenovirus 3 is a potent facilitator of dendritic cell therapy.. Poster presenterad vid ESMO immuno-oncology conference 2017, Geneva, Schweiz.